by Manoranjan Das | Aug 28, 2025 | By Manoranjan Das, Commercial Planning
Why Targeting and Segmentation as a service Bringing a drug to market is never simple—especially in today’s fast-evolving healthcare landscape. For pharmaceutical and biotech companies, one of the toughest hurdles is reaching the right audience—whether that’s...
by Manoranjan Das | May 26, 2025 | By Manoranjan Das
Commercialising a drug is never easy—especially for small to medium-sized pharmaceutical and biotech companies. One of the biggest hurdles? Measuring and optimising field force effectiveness (SFE). While many companies invest in CRM systems to track field activities,...
by admin | Sep 15, 2020 | By Manoranjan Das, Formulary Analytics
The NHS drugs bill is estimated to be £20 billion in 2020/21. This is a massive market for any pharmaceutical company big or small to ignore but same time complex to penetrate. A new innovative drug doesn’t guarantee anyone will buy the medicine. For commercial...
